About our Project

Welcome to the EPOC-doxorubicin pharmacology study website.  Recruitment to the study began in 2010 and the target 100 paediatric patients was reached in October 2012.  Analysis of the patient pharmacokinetic, pharmacodynamic and pharmacogenetic samples is currently underway and the study is due to report out later this year.